{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:26:48Z","timestamp":1793305608139,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"9-10","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.cca.2011.01.022","type":"journal-article","created":{"date-parts":[[2011,1,26]],"date-time":"2011-01-26T09:17:02Z","timestamp":1296033422000},"page":"709-712","source":"Crossref","is-referenced-by-count":118,"title":["Plasma YKL-40 levels in healthy subjects from the general population"],"prefix":"10.1016","volume":"412","author":[{"given":"Stig E.","family":"Bojesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia S.","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge G.","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2011.01.022_bb0005","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1373\/clinchem.2010.146530","article-title":"Plasma YKL-40 and total and disease-specific mortality in the general population","volume":"56","author":"Johansen","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2011.01.022_bb0010","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ana.22220","article-title":"Elevated plasma YKL-40 levels and ischemic stroke in the general population","volume":"68","author":"Kjaergaard","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cca.2011.01.022_bb0015","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1200\/JCO.2008.18.8367","article-title":"Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population","volume":"27","author":"Johansen","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cca.2011.01.022_bb0020","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2217\/fon.09.66","article-title":"Plasma YKL-40: a potential new cancer biomarker?","volume":"5","author":"Johansen","year":"2009","journal-title":"Rev Future Oncol"},{"key":"10.1016\/j.cca.2011.01.022_bb0025","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/eurheartj\/ehp049","article-title":"High serum YKL-40 concentration in patients with stable coronary artery disease is associated with increased risk of myocardial infarction, cardiovascular death, and all-cause mortality","volume":"30","author":"Kastrup","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cca.2011.01.022_bb0030","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.2337\/db08-0182","article-title":"Plasma YKL-40: a BMI-independent marker of type 2 diabetes","volume":"57","author":"Nielsen","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2011.01.022_bb0035","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.4049\/jimmunol.181.7.5167","article-title":"YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages","volume":"181","author":"Letuve","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.cca.2011.01.022_bb0040","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/gut.2010.207423","article-title":"Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C","volume":"59","author":"Fontana","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.cca.2011.01.022_bb0045","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa073600","article-title":"A chitinase-like protein in the lung and circulation of patients with severe asthma","volume":"357","author":"Chupp","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2011.01.022_bb0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02686089","article-title":"Is the sugar always sweet in intestinal inflammation?","volume":"37","author":"Mizoguchi","year":"2007","journal-title":"Immunol Res"},{"key":"10.1016\/j.cca.2011.01.022_bb0055","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1158\/1055-9965.EPI-07-2766","article-title":"Diurnal, weekly and long-time variation in serum concentrations of YKL-40 in healthy subjects","volume":"17","author":"Johansen","year":"2008","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.cca.2011.01.022_bb0060","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/jnci\/djg005","article-title":"Integrin \u03b23, Leu33Pro homozygosity and risk of cancer","volume":"95","author":"Bojesen","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cca.2011.01.022_bb0065","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1084\/jem.20040111","article-title":"A population-based study of morbidity and mortality in mannose-binding lectin deficiency","volume":"199","author":"Dahl","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.cca.2011.01.022_bb0070","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa0707402","article-title":"Genetically elevated C-reactive protein and ischemic vascular disease","volume":"359","author":"Zacho","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2011.01.022_bb0075","first-page":"354","article-title":"The Danish registers of causes of death","volume":"46","author":"Juel","year":"1999","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.cca.2011.01.022_bb0080","first-page":"535","article-title":"The Danish Cancer Registry\u2014history, content, quality and use","volume":"44","author":"Storm","year":"1997","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.cca.2011.01.022_bb0085","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/clinchem\/44.3.509","article-title":"Chondrex: new marker of joint disease","volume":"44","author":"Harvey","year":"1998","journal-title":"Clin Chem"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T01:13:42Z","timestamp":1592270022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898111000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":17,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0009898111000313"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2011.01.022","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}